Clinical Trial Update: Effect of Extensively Hydrolyzed Liquid Human Milk Fortifier on Growth and Tolerance in Moderately Premature Infants [Phase 4]

View source ↗

Summary

Phase 4 trial evaluating the growth and tolerance effects of extensively hydrolyzed liquid human milk fortifier in moderately premature infants has completed.

Upgrade for the full analysis, importance score, and drug timeline.

Diseases / indications

• Complications of Prematurity
• Premature Birth Complications

Drugs mentioned

• Extensively Hydrolyzed Liquid Human Milk Fortifier

Snippet

Sponsor: University of Kansas Medical Center | Conditions: Complication of Prematurity | Phase 4 | Status: COMPLETED